Main > PHARMA. > Chiral Pharmaceuticals > Racemate Resolution (Sepn.) > Kinetic Resolution (Cyclic Subst.) > Patent > Claims > Claim 1: StereoSelective Chemical > Synthesis Comprise: Reacting > NUCLEOPHILE & Chiral CYCLIC > Substrate in presence of > Chiral Non-Racemic CATALYST > to produce ee Prodt & Catalyst > Residue in 1st Oxidation State > with Prodt Degradation Activity; & > Chemical Change to 2nd Oxidation > State with REDUCED Activity > Claim 4: Cyclic Substrate Selected: > EPOXIDES; Aziridines; Episulfides; > Cyclic (Thio)Carbonates; > Cyclic Phosphates; (Thio)Lactams; > Cyclic Sulfates; Cyclic Sulfites; > (Thio)Lactones & Sultones. Claim 5: > Nucleophile: Water; PhenOxides; > HydrOxides; AlkOxides; Alcohols; > Thiols, Thiolates, Carboxylic Acids > & Carboxylates. Claim 6 Nucleophile > Select: Water; Phenols; & > Carboxylic Acids. Claim 8: Catalyst > : Chiral MetalloSALENate. Claim 14 > Hydrolytic Kinetic Resolution. > Claim 15: Nucleophile Phenol. > Cyclic Substrate Epoxide. > Catalyst s 1st Oxidation State
Catalyst s 1st Oxidation State's subsections
Active in UnDesired Epoxide Form.
Catalyst s 1st Oxidation State's products
This section has no products